Page 2 - Peter Wrighton Smith News Today

Oxford Immunotec will perform T cell testing on participants receiving Valnevas vaccine candidate - News - PharmaTimes

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Oxford Immunotec’s T-SPOT® Discovery SARS-CoV-2 Test is Used to Measure the Efficacy of ... Oxford Immunotec Global PLCJanuary 13, 2021 GMT OXFORD, United Kingdom and MARLBOROUGH, Mass., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company, announce the start of a collaboration with Valneva. The Company will perf...

PerkinElmer buying UK diagnostics firm for $591 million By Anissa Gardizy Globe Staff,Updated January 7, 2021, 4:03 p.m. Email to a Friend A PerkinElmer automated workstation, which is used in labs around the world. On Thursday, the company announced it would acquire Oxford Immunotec, which makes tests for diagnosing tuberculosis.- PerkinElmer announced on Thursday it will acquire UK diagnostics company Oxford Immunotec in a deal worth $591 million. The Waltham-based firm makes lab equipment an...

PerkinElmer, Inc.: PerkinElmer to Acquire Oxford Immunotec Global PLC Transaction expected to be completed in the first half of 2021 PerkinElmer, Inc. (NYSE: PKI) (" Oxford Immunotec" or the " Company") are pleased to announce they have reached an agreement on terms under which PerkinElmer will acquire Oxford Immunotec (the " Acquisition"). It is intended that the Acquisition will be implemented by means of a U.K. High Court of Justice-sanctioned scheme of arrangement under Part 26 of the U.K. ...

By Andrew Smith Environmental responsibility has now become policy with the vast majority of businesses. But back in 1997, at the time of the groundbreaking Kyoto agreement, it was hardly a consideration. Kyoto tried to commit industrialised nations to cut carbon pollution by 5.2 per cent below 1990 levels. Some have been more successful than others but one way of achieving it was to develop a system of carbon credits which larger bu...

The research, among 2,847 key workers from the NHS, police and fire service in June, found that 25 per cent of participants had high levels of T-cells which recognised Covid.  That is far higher than the results of antibody surveys, which have consistently found no more than six per cent test positive for having had Covid.  And it is likely to be even higher now that the country has experienced a second wave of infections. Experts at Cambridge University’s MRC Biostatistics Unit estimate 7...

News Category Global Banking & Finance Reviews Oxford Immunotec Announces the Foundation of the Global T Cell Expert Consortium, Whose First Meeting Took Place This Week Oxford Immunotec Announces the Foundation of the Global T Cell Expert Consortium, Whose First Meeting Took Place This Week OXFORD, United Kingdom and MARLBOROUGH, Mass., Dec. 16, 2020 — Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company, announce the formation and initial...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Oxford Immunotec Announces the Foundation of the Global T Cell Expert Consortium, Whose First ... Oxford Immunotec Global PLCDecember 16, 2020 GMT OXFORD, United Kingdom and MARLBOROUGH, Mass., Dec. 16, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company, announce the formation and initial meeting of the Global T cell exper...

(2) OXFORD, United Kingdom and MARLBOROUGH, Mass., Dec. 16, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the "Company"), a global, high-growth diagnostics company, announce the formation and initial meeting of the Global T cell expert consortium (GTEC). The GTEC is a community of experts in T cell research, epidemiology, vaccine research and global public health. It aims to be the leading voice for T cell expertise during and beyond the current COVID-19 pandemic. The G...

Oxford Immunotec Global PLC Oxford Immunotec Announces the Foundation of the Global T Cell Expert Consortium, Whose First Meeting Took Place This Week Oxford Immunotec Announces the Foundation of the Global T Cell Expert Consortium, Whose First Meeting Took Place This Week OXFORD, United Kingdom and MARLBOROUGH, Mass., Dec. 16, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company, announce the formation and initial ...